Karen Ballen, MD

Massachusetts General HospitalBoston, Massachusetts - 02114 |
- CLINICAL TRIALS 4
- CONDITIONS9
- INTERVENTIONS18
- SINCE2005

Reduced Intensity Sequential Double Umbilical Cord Blood Transplantation Using Prostaglandin E2 (PGE2)
April 2009 - December 2011

A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia
November 2007 - November 2010

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
April 2005 - September 2011

Treatment of Older Adults With Acute Lymphoblastic Leukemia
August 2009 - June 2012
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphoid
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic Syndromes
Preleukemia
Hematologic Neoplasms
Melphalan
Fludarabine
Prednisone
Lenalidomide
Methotrexate
Tacrolimus
Cytarabine
Bortezomib
Sirolimus
Clofarabine
Doxorubicin
Vincristine
Antithymocyte Globulin
Peg-Asparaginase
Ex-Vivo 16, 16 Dimethyl-Prostaglandin E2 Expansion
Dendritic Cell Tumor Fusion
Imatinib
6 Mercaptopurine



